Tonix Pharmaceuticals Holding Corp. (TNXP)
6.42
+0.02
(+0.31%)
USD |
NASDAQ |
Oct 15, 16:00
6.53
+0.11
(+1.71%)
After-Hours: 20:00
Tonix Pharmaceuticals Cash from Operations (TTM) : -155.18M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -155.18M |
| March 31, 2026 | -129.49M |
| December 31, 2025 | -103.75M |
| September 30, 2025 | -77.30M |
| June 30, 2025 | -66.78M |
| March 31, 2025 | -60.07M |
| December 31, 2024 | -61.07M |
| September 30, 2024 | -68.72M |
| June 30, 2024 | -73.26M |
| March 31, 2024 | -87.98M |
| December 31, 2023 | -103.32M |
| September 30, 2023 | -104.43M |
| June 30, 2023 | -103.14M |
| March 31, 2023 | -99.00M |
| December 31, 2022 | -97.14M |
| September 30, 2022 | -96.68M |
| June 30, 2022 | -85.96M |
| March 31, 2022 | -84.92M |
| December 31, 2021 | -74.93M |
| September 30, 2021 | -67.11M |
| June 30, 2021 | -71.09M |
| March 31, 2021 | -62.17M |
| December 31, 2020 | -50.43M |
| September 30, 2020 | -42.56M |
| June 30, 2020 | -32.89M |
| Date | Value |
|---|---|
| March 31, 2020 | -27.48M |
| December 31, 2019 | -26.79M |
| September 30, 2019 | -26.73M |
| June 30, 2019 | -24.85M |
| March 31, 2019 | -25.43M |
| December 31, 2018 | -23.56M |
| September 30, 2018 | -21.85M |
| June 30, 2018 | -21.86M |
| March 31, 2018 | -21.05M |
| December 31, 2017 | -19.07M |
| September 30, 2017 | -19.64M |
| June 30, 2017 | -23.08M |
| March 31, 2017 | -26.62M |
| December 31, 2016 | -37.32M |
| September 30, 2016 | -43.78M |
| June 30, 2016 | -47.71M |
| March 31, 2016 | -48.95M |
| December 31, 2015 | -42.52M |
| September 30, 2015 | -38.82M |
| June 30, 2015 | -31.37M |
| March 31, 2015 | -27.83M |
| December 31, 2014 | -22.84M |
| September 30, 2014 | -18.15M |
| June 30, 2014 | -16.16M |
| March 31, 2014 | -11.22M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | -80.58M |
| Nektar Therapeutics | -233.79M |
| Heron Therapeutics, Inc. | -11.61M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |